T2 Biosystems ROA 2024

T2 Biosystems Aktienanalyse

What does T2 Biosystems do?

T2 Biosystems Inc. is an American company that was founded in 2006. The company is based in Lexington, Massachusetts. The founders of T2 Biosystems aimed to create an innovative diagnostic system that could improve hospital performance. Their business model is based on the development, manufacturing, and distribution of innovative instruments and diagnostic solutions. T2 Biosystems operates in various sectors, with a focus on diagnosis and healthcare solutions. The key areas are: 1. Infectious diseases: T2 Biosystems develops systems that enable rapid and accurate diagnosis of infectious diseases in hospitals and other medical facilities. The team has already made significant progress in detecting infections such as sepsis, pneumonia, and other diseases that require prompt diagnosis to increase patient survival rates. 2. Hematology: The company has also developed a product called T2HemoStat, which improves accuracy in determining biomarkers in blood samples. HemoStat allows for real-time analysis of patient samples to achieve faster results than current standard tests. 3. Healthcare: T2 Biosystems also offers solutions to improve healthcare. The goal is to address issues in healthcare by using data and information more intelligently. The company is working on products tailored to the needs of hospitals and healthcare providers. T2 Biosystems pursues a collaborative strategy, fostering cooperation among clinics, customers, and companies. T2 Biosystems has successfully launched several products, including the T2Dx instrument, which enables rapid and accurate detection of infections. The measurement system is based on T2 Magnetic Resonance (T2MR) technology, which can identify cells and biomolecules based on magnetic resonance. The T2Dx system is also capable of identifying drugs directly in the tests, allowing for better utilization of antibiotics to combat resistant bacteria. In collaboration with Harvard Medical School, the company is also working on developing specific tests focused on the detection of bacteria or viruses. The team at T2 Biosystems has developed an innovative system that allows for the analysis of bacterial or viral strains. T2 Biosystems has a rapidly growing customer base and is a key player in the healthcare market. The company has already established important partnerships with some of the leading hospitals in the US and continues to work on forming further partnerships in other parts of the world. The products of T2 Biosystems have received numerous awards, including the "Best of Show" prize at the Association of Clinical Chemistry Annual Meeting and the "Medical Device Excellence Award" from the Massachusetts Medical Device Industry Council. The company operates in a highly competitive market. To remain competitive, T2 Biosystems heavily invests in research and development. The company also has a strong presence on social media to raise awareness of their products and services. T2 Biosystems aims to achieve further medical advancements and develop innovative technologies to improve patient care in the future. T2 Biosystems ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding T2 Biosystems's Return on Assets (ROA)

T2 Biosystems's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing T2 Biosystems's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider T2 Biosystems's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in T2 Biosystems’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about T2 Biosystems stock

What is the Return on Assets (ROA) of T2 Biosystems this year?

The Return on Assets (ROA) of T2 Biosystems is -1.44 undefined this year.

What was the ROA of T2 Biosystems compared to the previous year?

The ROA of T2 Biosystems has increased by -20.74% compared to the previous year.

What consequences do high ROA have for investors of T2 Biosystems?

A high ROA is advantageous for investors of T2 Biosystems, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in T2 Biosystems?

A low ROA can be unfavorable for investors of T2 Biosystems as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of T2 Biosystems affect the company?

An increase in ROA of T2 Biosystems can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of T2 Biosystems impact the company?

A reduction in the ROA of T2 Biosystems can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of T2 Biosystems?

Some factors that can influence the ROA of T2 Biosystems include revenue, operating costs, asset structure, and industry average.

Why is the ROA of T2 Biosystems important for investors?

The ROA of T2 Biosystems is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can T2 Biosystems take to improve ROA?

To improve ROA, T2 Biosystems can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does T2 Biosystems pay?

Over the past 12 months, T2 Biosystems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, T2 Biosystems is expected to pay a dividend of 0 USD.

What is the dividend yield of T2 Biosystems?

The current dividend yield of T2 Biosystems is .

When does T2 Biosystems pay dividends?

T2 Biosystems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of T2 Biosystems?

T2 Biosystems paid dividends every year for the past 0 years.

What is the dividend of T2 Biosystems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is T2 Biosystems located?

T2 Biosystems is assigned to the 'Health' sector.

Wann musste ich die Aktien von T2 Biosystems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of T2 Biosystems from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did T2 Biosystems pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of T2 Biosystems in the year 2023?

In the year 2023, T2 Biosystems distributed 0 USD as dividends.

In which currency does T2 Biosystems pay out the dividend?

The dividends of T2 Biosystems are distributed in USD.